Coralville, Iowa (November 20, 2018) – Infection control leader CIVCO Medical Solutions will present Envision, the next generation of ultrasound probe covers and scan pads at this year’s Radiological Society of North America (RSNA) annual meeting in Chicago, IL, November 25-29.
Envision ultrasound probe covers and scan pads are viral barriers allowing for 100% gel-free ultrasound procedures. Radiology physicians and clinicians simply activate Envision with a sterile liquid to perform ultrasound procedures, removing the need for gel. The elimination of gel from procedures utilizing Envision can improve the quality of FNA specimens, reduces the risk of contamination, and simplifies workflow.
Improve the quality of FNA specimens
Envision covers can help improve the visibility of cells in fine needle aspirations (FNAs) by eliminating the need for gel from these procedures. Several studies show the adverse effects gel can have on FNAs:
Reduce the risk of contamination
The removal of gel when using Envision can help reduce the risk of contamination during needle-guided ultrasound interventions or while scanning non-intact skin. Ultrasound gel has been shown to harbor and spread infection and can:
The Envision ultrasound probe cover and scan pad enable physicians and clinicians to simplify workflow throughout a procedure.
Visit CIVCO’s booth #2407 at RSNA to try Envision and learn about its many benefits during ultrasound procedures.
Envision is 510(k) clearance pending.
Visit www.CIVCO.com/envision to learn more.
CIVCO Medical Solutions has over 35 years of experience and offers cutting-edge medical technology to a diverse group of medical professionals. CIVCO designs and manufactures accessories for use in diagnostic and therapeutic imaging and interventional procedures with a strong focus on ultrasound. CIVCO’s specialties include: infection control (ultrasound probe and system covers), high-level disinfection of ultrasound probes, needle and device guidance, electromagnetic needle tracking, and transperineal prostate solutions. Corporate information is available at www.CIVCO.com.
For more information or product images, please contact:
CIVCO Medical Solutions
1. A. Lalzad, D. Ristitsch, W. Downey, A. F. Little and M. E. Schneider-Kolsky “Effect of ultrasound transmission gel on ultrasound-guided fine needle aspiration cytological specimens of thyroid” Cytopathology 2012, 23, 330–333
2. A. J. Molyneux, S. B. Coghill “Cell Lysis Due to Ultrasound Gel In Fine Needle Aspirates; an Important New Artefact In Cytology” Cytopathology 1994 5, 41-45
3. Royer MC, Davidson DD, Dimitrov RK, Kuo CY, Kokaska MS “Ultrasound gel causes fine needle aspiration artifact? A clear choice.” Acta Cytol. 2012;56(2):146-54
4. Oleszkowicz SC, Chittick P, Russo V, Keller P, Sims M, Band J. “Infections Associated with Use of Ultrasound Transmission Gel: Proposed Guidelines to Minimize Risk” Infection Control and Hospital Epidemiology Dec. 2012, vol. 33, no. 12
5. Esteban C. Nannini, Adriana Ponessa, Rosa Muratori, Patricia Marchiaro, Viviana Ballerini, Luis Flynn, Adriana S. Limansky “Polyclonal outbreak of bacteremia caused by Burkholderia cepacia complex and the presumptive role of ultrasound gel” The Brazilian Journal of Infectious Diseases 2015;19(5);543-545
6. Shaban RZ, Maloney S, Gerrard J, Collignon P, Macbeth D, Cruickshank M, Hume A, Jennison AV, Graham RMA, Bergh H, Wilson HL, Derrington P “Outbreak of health care-associated Burkholderia cenocepacia bacteremia and infection attributed to contaminated sterile gel used for central line insertion under ultrasound guidance and other procedures” AJIC 45 (2017) 954-8
7. Centers for Disease Control and Prevention “Pseudomonas aeruginosa respiratory tract infections associated with contaminated ultrasound gel used for transesophageal echocardiography - Michigan, December 2011-January 2012.” MMWR Morb Mortal Wkly Rep. 2012 Apr 20;61:262-4.
8. William A. Rutala, Ph.D., M.P.H.1,2, David J. Weber, M.D., M.P.H.1,2, and the Healthcare Infection Control Practices Advisory Committee “CDC - Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008” www.cdc.gov/infectioncontrol/pdf/guidelines/disinfection-guidelines.pdf
9. Australian Government Department of Health Therapeutic Goods Administration “Safety Advisory – risk of bacterial contamination” 2017 https://www.tga.gov.au/alert/meditech-ultrasound-gel
COPYRIGHT © 2018. CIVCO IS A REGISTERED TRADEMARK OF CIVCO MEDICAL SOLUTIONS. ENVISION IS A TRADEMARK OF CIVCO. ALL PRODUCTS MAY NOT BE LICENSED IN ACCORDANCE WITH CANADIAN LAW. 2018C-3096 REV 1